P. Fumoleau - Concepedia

Author

P. Fumoleau

Also Known As

A Monnier, Fumoleau, Pierre, Jean-Marc Vrigneaud, P FUMOLEAU, P Fumoleau, P. FUMOLEAU, P. Fumoleau, PIERRE FUMOLEAU, Pierre Fumoleau

487

Publications

21.3K

Citations

H-Index

120

Concepts

All Affiliations

Centre Georges François Leclerc Institut Curie European Organisation for Research and Treatment of Cancer Inserm Centre Eugène Marquis

About

P. Fumoleau is an author at Centre Georges François Leclerc specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	123	8K
2	Health Sciences	15	17	784
3	Public Health	7	7	334
4	Biostatistics	4	4	540
5	Engineering	1	1	11

P. Fumoleau

199

Publications

19.9K

Citations

H-Index

Page 1

	Year	Citations
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. C. Focan, S. M. Steinberg, M Blichert-Toft, PubMed	1998	2.2K
Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results Joyce O’Shaughnessy, David Miles, Svetislava J. Vukelja, Journal of Clinical Oncology	2002	1.1K
Identification of molecular apocrine breast tumours by microarray analysis Pierre Farmer, Hervé Bonnefoi, Véronique Becette, Oncogene Tumor BiologyBreast OncologyPathologyBreast CancerMicroarray Analysis	2005	736
Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy José Baselga, Karen A. Gelmon, Shailendra Verma, Journal of Clinical Oncology	2010	628
Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial Henri Roché, P. Fumoleau, M. Spielmann, Journal of Clinical Oncology	2006	570
Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer. René Bruno, Darcy A. Hille, A. Riva, Journal of Clinical Oncology	1998	418
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer. J.-M. Nabholtz, Karen A. Gelmon, M. Bontenbal, Journal of Clinical Oncology	1996	382
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial X. Pivot, Gilles Romieu, Marc Debled, The Lancet Oncology Breast OncologyMedicineRandomised Phase 3Clinical TrialsBreast Cancer	2013	337
Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy. P. Fumoleau, F.M. Delgado, T. Delozier, Journal of Clinical Oncology	1993	327
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin M. Borner, Patrick Schöffski, Ronald de Wit, European Journal of Cancer Intravenous FluorouracilPharmacologyPatient PreferencePharmacotherapyMedicine	2002	314

Page 1